This article needs additional citations for verification. Please help improve this articlebyadding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Guacetisal" – news · newspapers · books · scholar · JSTOR (November 2023) (Learn how and when to remove this message) |
![]() | |
Clinical data | |
---|---|
Trade names | Broncaspin; Balsacetil; Guaiaspir; Prontomucil |
Other names | Aspirin guaiacol ester; O-Methoxyphenyl salicylate acetate |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.054.221 ![]() |
Chemical and physical data | |
Formula | C16H14O5 |
Molar mass | 286.283 g·mol−1 |
3D model (JSmol) | |
Melting point | 72 to 74.5 °C (161.6 to 166.1 °F) |
| |
|
Guacetisal is a drug that has been used to treat inflammatory respiratory diseases.[1] Chemically, it is an ester resulting from the combination of aspirin and guaiacol.[citation needed]
| |
---|---|
pyrazolones / pyrazolidines |
|
salicylates |
|
acetic acid derivatives and related substances |
|
oxicams |
|
propionic acid derivatives (profens) |
|
n-arylanthranilic acids (fenamates) |
|
COX-2 inhibitors (coxibs) |
|
other |
|
NSAID combinations |
|
Key: underline indicates initially developed first-in-class compound of specific group; #WHO-Essential Medicines; †withdrawn drugs; ‡veterinary use. | |
|
![]() | This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |